FIELD: medicine.
SUBSTANCE: after primary virus remission, Ronkoleukine is introduced in dosage 500 mg with water 200 ml after supper within common interferon therapy, thus taking two courses 5-10 times every second day or 2 times a week. After the third introduction of Ronkoleukine, Likopide is additionally introduced in daily dosage 10 mg once a day within 10 days. Interval between courses is 2 months. If necessary courses are repeated.
EFFECT: prevented disease recurrence and eliminated immunodeficiency manifestation.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF CHRONIC VIRAL HEPATITIS TYPE C | 2006 |
|
RU2345787C2 |
| METHOD OF CHRONIC VIRUS HEPATITIS B TREATMENT | 2006 |
|
RU2365381C2 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF ANTIVIRAL THERAPY OF CHRONIC HEPATITIS B | 2011 |
|
RU2469327C1 |
| METHOD OF PREDICTING BY BIOCHEMICAL PARAMETRES CHRONIC HEPATITIS C TREATMENT OUTCOME AFTER THREE MONTHS SINCE BEGINNING OF ANTIVIRAL THERAPY | 2009 |
|
RU2408283C1 |
| METHOD OF TREATING VIRAL HEPATITIS C | 2012 |
|
RU2496512C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC VIRAL HEPATITIS TYPE C, GENOTYPE 3a | 2009 |
|
RU2400229C1 |
| METHOD FOR BASIC TREATMENT OF CHRONIC VIRAL HEPATITIS C | 2005 |
|
RU2306134C2 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF INTERFERON THERAPY OF CHRONIC HEPATITIS C IN CHILDREN | 2012 |
|
RU2486526C1 |
| METHOD FOR PREDICTION OF ANTIRETROVIRAL THERAPY OUTCOMES IN CHRONIC HEPATITIS B | 2014 |
|
RU2571493C2 |
| METHOD OF PREVENTING VERTICAL TRANSMISSION OF HEPATITIS B AND C VIRUSES IN PREGNANT WOMEN WITH REACTIVATION OF VIRUSES IN THIRD TRIMESTER | 2011 |
|
RU2473341C1 |
